Single‐chain antibody variable region‐targeted interleukin‐2 stimulates T cell killing of human colorectal carcinoma cells

Authors:

Abstract
Summary: Recombinant DNA techniques were used to clone, construct and express the bifunctional molecule FV/IL‐2. The FV/IL‐2 is a single‐chain 37kDa fusion protein expressed in Escherichia coli under control of the strong T7 bacteriophage promoter in the expression vector pT7‐7‐FV‐lL‐2. The fused gene fragment FV‐IL‐2 contains a single‐chain anti‐TAG72 FV gene fragment and the human recombinant cDNA fragment of the IL‐2 molecule. The renatured soluble form of FV/IL‐2 was purified from E. coli inclusion bodies using hydroxylapatite chromatography. The yield of this fusion protein was estimated at 2.0 mg/L. Our data showed that the FV/IL‐2 molecule retained the TAG72 antigen‐binding specificity and the IL‐2 activity as measured in the standard T cell proliferation as well as cytotoxicity assays. Therefore, it may prove to be useful in targeting the biological effect of lL‐2 to tumour cells and stimulating its immune destruction.